SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-069216
Filing Date
2023-06-08
Accepted
2023-06-08 10:21:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2317653-7_424b5.htm 424B5 588534
2 GRAPHIC lg_nrx-4clr.jpg GRAPHIC 44375
  Complete submission text file 0001104659-23-069216.txt   650508
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265492 | Film No.: 231001006
SIC: 2834 Pharmaceutical Preparations